Literature DB >> 19321415

Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy.

Kyle E Broaders1, Joel A Cohen, Tristan T Beaudette, Eric M Bachelder, Jean M J Fréchet.   

Abstract

Materials that combine facile synthesis, simple tuning of degradation rate, processability, and biocompatibility are in high demand for use in biomedical applications. We report on acetalated dextran, a biocompatible material that can be formed into microparticles with degradation rates that are tunable over 2 orders of magnitude depending on the degree and type of acetal modification. Varying the degradation rate produces particles that perform better than poly(lactic-co-glycolic acid) and iron oxide, two commonly studied materials used for particulate immunotherapy, in major histocompatibility complex class I (MHC I) and MHC II presentation assays. Modulating the material properties leads to antigen presentation on MHC I via pathways that are dependent or independent of the transporter associated with antigen processing. To the best of our knowledge, this is the only example of a material that can be tuned to operate on different immunological pathways while maximizing immunological presentation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19321415      PMCID: PMC2666992          DOI: 10.1073/pnas.0901592106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  A macromolecular delivery vehicle for protein-based vaccines: acid-degradable protein-loaded microgels.

Authors:  Niren Murthy; Mingcheng Xu; Stephany Schuck; Jun Kunisawa; Nilabh Shastri; Jean M J Fréchet
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-18       Impact factor: 11.205

2.  Sonication parameters for the preparation of biodegradable nanocapsules of controlled size by the double emulsion method.

Authors:  Ugo Bilati; Eric Allémann; Eric Doelker
Journal:  Pharm Dev Technol       Date:  2003       Impact factor: 3.133

3.  A novel strategy for encapsulation and release of proteins: hydrogels and microgels with acid-labile acetal cross-linkers.

Authors:  Niren Murthy; Yi X Thng; Stephany Schuck; Ming C Xu; Jean M J Fréchet
Journal:  J Am Chem Soc       Date:  2002-10-23       Impact factor: 15.419

Review 4.  Dendritic cells in cancer immunotherapy.

Authors:  L Fong; E G Engleman
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

5.  Assay of reducing end-groups in oligosaccharide homologues with 2,2'-bicinchoninate.

Authors:  L W Doner; P L Irwin
Journal:  Anal Biochem       Date:  1992-04       Impact factor: 3.365

6.  Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo.

Authors:  Lianjun Shen; Luis J Sigal; Marianne Boes; Kenneth L Rock
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

7.  Acetal-derivatized dextran: an acid-responsive biodegradable material for therapeutic applications.

Authors:  Eric M Bachelder; Tristan T Beaudette; Kyle E Broaders; Jesse Dashe; Jean M J Fréchet
Journal:  J Am Chem Soc       Date:  2008-07-17       Impact factor: 15.419

8.  Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range.

Authors:  S Udenfriend; S Stein; P Böhlen; W Dairman; W Leimgruber; M Weigele
Journal:  Science       Date:  1972-11-24       Impact factor: 47.728

9.  Measurement of ligand-induced activation in single viable T cells using the lacZ reporter gene.

Authors:  J Karttunen; N Shastri
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

10.  Poly(lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells.

Authors:  Mutsumi Yoshida; Julia E Babensee
Journal:  J Biomed Mater Res A       Date:  2004-10-01       Impact factor: 4.396

View more
  61 in total

1.  Comparison of PLA microparticles and alum as adjuvants for H5N1 influenza split vaccine: adjuvanticity evaluation and preliminary action mode analysis.

Authors:  Weifeng Zhang; Lianyan Wang; Yuan Liu; Xiaoming Chen; Jiahui Li; Tingyuan Yang; Wenqi An; Xiaowei Ma; Ruowen Pan; Guanghui Ma
Journal:  Pharm Res       Date:  2013-10-30       Impact factor: 4.200

2.  Polymer blend particles with defined compositions for targeting antigen to both class I and II antigen presentation pathways.

Authors:  Kenny K Tran; Xi Zhan; Hong Shen
Journal:  Adv Healthc Mater       Date:  2013-10-02       Impact factor: 9.933

3.  Tunable degradation of acetalated dextran microparticles enables controlled vaccine adjuvant and antigen delivery to modulate adaptive immune responses.

Authors:  Naihan Chen; Monica M Johnson; Michael A Collier; Matthew D Gallovic; Eric M Bachelder; Kristy M Ainslie
Journal:  J Control Release       Date:  2018-02-02       Impact factor: 9.776

4.  Inflammation responsive logic gate nanoparticles for the delivery of proteins.

Authors:  Enas A Mahmoud; Jagadis Sankaranarayanan; José M Morachis; Gloria Kim; Adah Almutairi
Journal:  Bioconjug Chem       Date:  2011-07-05       Impact factor: 4.774

5.  Immunopotentiator-Loaded Polymeric Microparticles as Robust Adjuvant to Improve Vaccine Efficacy.

Authors:  Weifeng Zhang; Lianyan Wang; Tingyuan Yang; Yuan Liu; Xiaoming Chen; Qi Liu; Jilei Jia; Guanghui Ma
Journal:  Pharm Res       Date:  2015-05-28       Impact factor: 4.200

6.  Investigation of tunable acetalated dextran microparticle platform to optimize M2e-based influenza vaccine efficacy.

Authors:  Naihan Chen; Matthew D Gallovic; Pamela Tiet; Jenny P-Y Ting; Kristy M Ainslie; Eric M Bachelder
Journal:  J Control Release       Date:  2018-09-24       Impact factor: 9.776

7.  Electrospray encapsulation of toll-like receptor agonist resiquimod in polymer microparticles for the treatment of visceral leishmaniasis.

Authors:  Anthony D Duong; Sadhana Sharma; Kevin J Peine; Gaurav Gupta; Abhay R Satoskar; Eric M Bachelder; Barbra E Wyslouzil; Kristy M Ainslie
Journal:  Mol Pharm       Date:  2013-02-12       Impact factor: 4.939

8.  Acetalated Dextran Microparticles for Codelivery of STING and TLR7/8 Agonists.

Authors:  Michael A Collier; Robert D Junkins; Matthew D Gallovic; Brandon M Johnson; Monica M Johnson; Andrew N Macintyre; Gregory D Sempowski; Eric M Bachelder; Jenny P-Y Ting; Kristy M Ainslie
Journal:  Mol Pharm       Date:  2018-10-15       Impact factor: 4.939

9.  Engineered Nanoplatelets for Enhanced Treatment of Multiple Myeloma and Thrombus.

Authors:  Quanyin Hu; Chenggen Qian; Wujin Sun; Jinqiang Wang; Zhaowei Chen; Hunter N Bomba; Hongliang Xin; Qundong Shen; Zhen Gu
Journal:  Adv Mater       Date:  2016-09-14       Impact factor: 30.849

10.  Nanocomposite microparticles (nCmP) for the delivery of tacrolimus in the treatment of pulmonary arterial hypertension.

Authors:  Zimeng Wang; Julie L Cuddigan; Sweta K Gupta; Samantha A Meenach
Journal:  Int J Pharm       Date:  2016-08-26       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.